Cargando…
Infliximab and Etanercept Are Equally Effective in Reducing Enterocyte APOPTOSIS in Experimental Colitis
Loss of epithelial barrier integrity is considered an early step in the pathogenesis of Crohn's disease (CD), and the rate of enterocyte apoptosis is one of the determinants of the intestinal barrier function. Tumor necrosis factor-α (TNF-α), one of the major proinflammatory mediators in CD, is...
Autores principales: | Fries, Walter, Muja, Carmelo, Crisafulli, Carmela, Costantino, Giuseppe, Longo, Giuseppe, Cuzzocrea, Salvatore, Mazzon, Emanuela |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2452978/ https://www.ncbi.nlm.nih.gov/pubmed/18645606 |
Ejemplares similares
-
Role of Etanercept and Infliximab on Nociceptive Changes Induced by the Experimental Model of Fibromyalgia
por: Cordaro, Marika, et al.
Publicado: (2022) -
Effects of Liver × receptor agonist treatment on signal transduction pathways in acute lung inflammation
por: Crisafulli, Concetta, et al.
Publicado: (2010) -
TNF-α as a Therapeutic Target in Acute Pancreatitis — Lessons from Experimental Models
por: Malleo, Giuseppe, et al.
Publicado: (2007) -
Olprinone Attenuates the Acute Inflammatory Response and Apoptosis after Spinal Cord Trauma in Mice
por: Esposito, Emanuela, et al.
Publicado: (2010) -
Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
por: Henry, Alistair I, et al.
Publicado: (2011)